Publications

Detailed Information

Discordant ErbB2 status between primary gastric carcinomas and metastatic/recurrent carcinomas

DC Field Value Language
dc.contributor.authorKim, W.-
dc.contributor.authorKim, M.-
dc.contributor.authorLee, B.-
dc.date.accessioned2012-07-10T00:42:38Z-
dc.date.available2012-07-10T00:42:38Z-
dc.date.issued2009-09-
dc.identifier.citationEJC SUPPLEMENTS; Vol.7(2); 378-378ko_KR
dc.identifier.issn1359-6349-
dc.identifier.urihttps://hdl.handle.net/10371/78675-
dc.description.abstractBackground: To evaluate the ErbB2 status in primary gastric carcinoma
(GC) and secondary (metastatic or recurrent) lesions, 614 cases of GC
were examined.
ko_KR
dc.language.isoenko_KR
dc.publisherPERGAMON-ELSEVIER SCIENCE LTDko_KR
dc.titleDiscordant ErbB2 status between primary gastric carcinomas and metastatic/recurrent carcinomasko_KR
dc.typeConference Paperko_KR
dc.identifier.doi10.1016/S1359-6349(09)71279-0-
dc.citation.journaltitleEJC SUPPLEMENTS-
dc.description.tc0-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share